Ramsay Générale de Santé (GDS) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
19 Aug, 2026Executive summary
Revenue rose 5.8% year-over-year to €2,507.2 million for the half-year ended December 31, 2024, driven by activity growth and acquisitions, notably the Cosem primary care centers in France.
EBITDA remained stable at €284.6 million, with margin declining to 11.4% from 12.0% due to inflation, lower subsidies, and government tariff constraints.
Operating income fell 15.5% to €66.1 million, reflecting cost inflation and less favorable government support.
Net result attributable to the group was a loss of €43.1 million, with EPS at -€0.39, compared to -€0.16 a year earlier.
Patient satisfaction reached a record NPS of 73% in France, and 95% of French facilities achieved top quality certification.
Financial highlights
Revenue in France grew 7.2%, supported by the acquisition of 12 Cosem primary care centers and tariff increases.
Nordic countries saw 2.7% reported revenue growth, mainly from Swedish hospital activity and Norwegian tariff hikes.
Operating margin in France was pressured by inflation, wage increases, and reduced government support.
Net financial debt stood at €3,715.6 million at December 31, 2024, up from €3,610.9 million at June 2024, but down from €3,869.9 million a year earlier.
Net cash flow from operations increased 13.9% to €169.9 million.
Outlook and guidance
The French government’s activity-based support scheme was extended through December 2025, with €20.2 million recognized in H1 2024.
Management expects continued operational challenges from inflation and labor competition, but ongoing efficiency plans in the Nordics and new contracts (e.g., St Göran hospital) support future performance.
Ongoing negotiations with European governments, especially France, to secure fairer private sector funding and tariff adjustments.
Strategic plan "Yes We Care 2025" supported by recent long-term debt refinancing and repricing, providing financial stability for future growth.
Focus on expanding digital capabilities, outpatient, and primary care activities.
Latest events from Ramsay Générale de Santé
- Connecting Care 2030 targets 2–3% annual growth, margin gains, and digital-led integrated care.GDS
CMD 2026 - Revenue and EBITDA grew, margins held steady, and a new 2030 strategy will drive future growth.GDS
H2 2026 - Revenue up 4.7%, strong ESG progress, all resolutions approved, COSEM integration on track.GDS
Status update - Revenue up 6.5% but net loss of €53.9m as inflation and lower subsidies hit margins.GDS
H2 2024 - Revenue up 8.6% and EBITDA up 15.1%, driven by growth in France and Sweden.GDS
Q1 2025 - Revenue up 5.1% to €3.89bn, EBITDA stable, but net loss widened and leverage increased.GDS
Q3 2025 - Revenue and EBITDA grew despite funding cuts, with stable net loss and improved leverage.GDS
H2 2025 - Revenue up 2.6% and EBITDA up 6.5% year-over-year, with margin and leverage improvements.GDS
Q1 2026 - Revenue up 3.3% to €2.59bn, stable EBITDA, net loss narrows, strategic changes and funding pressures persist.GDS
H1 2026